SLAMF7 and Miyoshi myopathy: CS1, a cell-surface glycoprotein, and member of the SLAM family, is ubiquitously expressed on malignant plasma cells including MM from patients, with low-level expression on NK and CD8+ T cells, and almost undetectable levels on healthy tissues10–12.